Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin

  1. Martin J. O'Donnell, MB;
  2. Clive Kearon, MB, PhD; and
  3. Alexander G. Turpie, MB
  1. From McMaster University, Hamilton, Ontario L8V 1C3, Canada.

    IN RESPONSE:

    We appreciate the opportunity to respond to issues raised by Dr. Shojania. We agree that the therapeutic anti-Xa heparin level range for LMWH has not been rigorously evaluated; however, the high residual anti-Xa …

    « Previous | Next Article »Table of Contents